SCHEMBL5204396

SCHEMBL5204396

O=c1[nH]cncc1Oc1ccc(Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 4/20 0.43
PTGS2 P35354 4/20 0.43
KDM4C Q9H3R0 1/20 0.43
CDK8 P49336 5/20 0.41
PIM1 P11309 1/20 0.41
MAP2K2 P36507 1/20 0.41
MAP4K2 Q12851 1/20 0.41
CCNC P24863 4/20 0.41
HAO1 Q9UJM8 2/20 0.41
CCNT1 O60563 1/20 0.40
ICAM1 P05362 1/20 0.40
SELE P16581 1/20 0.40
VCAM1 P19320 1/20 0.40
CDK9 P50750 1/20 0.40
RHEB Q15382 1/20 0.40
S1PR1 P21453 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 1/20 0.39
PARP1 P09874 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17959988 0.83 LTA4H (0.51) PTGS1PTGS2KDM4C
SCHEMBL5204190 0.80 ICAM1 (0.43) KDM4CICAM1SELEVCAM1
SCHEMBL2882225 0.72 KMT2A (0.47) RHEBMEN1KMT2AALDH1A1
SCHEMBL9541196 0.72 PARP1 (0.56) PIM1MAP2K2MAP4K2CDK9RHEB
SCHEMBL5207646 0.71 KDM4C (0.41) PTGS1PTGS2KDM4CCDK8PIM1
SCHEMBL5202998 0.71 LTA4H (0.57) KDM4CCDK8PIM1MAP2K2MAP4K2
SCHEMBL11545424 0.69 PTGS1 (0.56) PTGS1PTGS2KDM4CCDK8PIM1
SCHEMBL24786432 0.69 PARP1 (0.45) KDM4CICAM1PARP1
SCHEMBL7708436 0.68 LMNA (0.52) PTGS1PTGS2KDM4CCDK8CCNC
SCHEMBL7716750 0.68 KDM4C (0.40) PTGS1PTGS2KDM4CCDK8CCNC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP disclosed
US-6916820-B1 Neurotrophic substituted pyrimidines KRENITSKY PHARMACEUTICALS, INC. (US) 2005-07-12 US disclosed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1165523-A1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES Krenitsky Pharmaceuticals, Inc. (US) 2002-01-02 EP disclosed
WO-2000061562-A1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC. (US) 2000-10-19 WO disclosed